Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 0.867
- -0.011-1.28%
Trading Mar 11 10:13 ET
3.39MMarket Cap0.00P/E (TTM)
0.889High0.860Low21.53KVolume0.860Open0.878Pre Close18.80KTurnover0.67%Turnover Ratio0.00P/E (Static)3.91MShares108.00052wk High-0.31P/B2.80MFloat Cap0.86052wk Low--Dividend TTM3.24MShs Float1091.250Historical High--Div YieldTTM3.27%Amplitude0.860Historical Low0.873Avg Price1Lot Size
Psyence Biomedical Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q2)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q2)Sep 30, 2022 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||
| Gross profit | ||||||
| Operating expense | 556.84%1.16M | 1,267.39%44.23M | -27.80%176.17K | 74.30%3.23M | 244K | 1.86M |
| Selling and administrative expenses | 382.11%890.48K | 10.52%1.8M | -23.72%184.7K | -5.40%1.63M | --242.15K | --1.72M |
| -Selling and marketing expense | 24,856.06%273.77K | 1,046.72%80.6K | --1.1K | -59.86%7.03K | --0 | --17.51K |
| -General and administrative expense | 235.88%616.71K | 6.02%1.72M | -24.18%183.61K | -4.84%1.62M | --242.15K | --1.7M |
| Research and development costs | 3,210.74%265.63K | -40.67%954.59K | -561.03%-8.54K | 1,072.35%1.61M | --1.85K | --137.24K |
| Depreciation amortization depletion | --1.02K | --240 | --0 | --0 | ---- | ---- |
| -Depreciation and amortization | --1.02K | --240 | --0 | --0 | ---- | ---- |
| Other operating expenses | ---- | --41.48M | ---- | ---- | ---- | ---- |
| Operating profit | -556.84%-1.16M | -1,267.39%-44.23M | 27.80%-176.17K | -74.30%-3.23M | -244K | -1.86M |
| Net non-operating interest income expense | 86.70%-3.72K | -3,369.43%-50.81K | -3,605.02%-27.94K | 1.55K | 797.0283 | 0 |
| Non-operating interest income | ---- | 37.32%2.13K | ---- | --1.55K | ---- | --0 |
| Non-operating interest expense | -86.70%3.72K | --52.94K | --27.94K | --0 | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | ---- | ---797.0283 | ---- |
| Other net income (expense) | 1,333.47%1.3M | -25,645.52%-6.87M | -7,101.52%-105.58K | 1,276.42%26.91K | -1.47K | -2.29K |
| Gain on sale of security | 103.16%3.34K | -1,247.98%-308.95K | -7,101.52%-105.58K | 1,276.42%26.91K | ---1.47K | ---2.29K |
| Special income (charges) | ---- | ---2.18M | ---- | --0 | ---- | ---- |
| -Less：Restructuring and merger&acquisition | ---- | --2.46M | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---281.5K | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | --1.3M | ---4.39M | ---- | ---- | ---- | ---- |
| Income before tax | 145.68%141.47K | -1,495.53%-51.16M | -26.57%-309.68K | -72.55%-3.21M | -244.67K | -1.86M |
| Income tax | ||||||
| Net income | 145.68%141.47K | -1,495.53%-51.16M | -26.57%-309.68K | -72.55%-3.21M | -244.67K | -1.86M |
| Net income continuous Operations | 145.68%141.47K | -1,495.53%-51.16M | -26.57%-309.68K | -72.55%-3.21M | ---244.67K | ---1.86M |
| Minority interest income | ||||||
| Net income attributable to the parent company | 145.68%141.47K | -1,495.53%-51.16M | -26.57%-309.68K | -72.55%-3.21M | -244.67K | -1.86M |
| Preferred stock dividends | ||||||
| Other preferred stock dividends | ||||||
| Net income attributable to common stockholders | 145.68%141.47K | -1,495.53%-51.16M | -26.57%-309.68K | -72.55%-3.21M | -244.67K | -1.86M |
| Basic earnings per share | 128.53%0.52 | -3,008.39%-586.5 | -26.57%-1.8223 | -72.55%-18.8683 | -1.4398 | -10.9349 |
| Diluted earnings per share | 127.99%0.51 | -3,008.39%-586.5 | -26.57%-1.8223 | -72.55%-18.8683 | -1.4398 | -10.9349 |
| Dividend per share | ||||||
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |